Newstral
Article
jdsupra.com on 2023-05-08 20:14
Second Circuit Affirms Dismissal Of RMBS-Related Claims Based On Lack Of Prudential Standing, Applying Issue Preclusion
Related news
- 2nd Circuit addresses issue preclusion standard in dismissal of RMBS actionsjdsupra.com
- First Department Affirms Partial Dismissal of RMBS Repurchase Claimsjdsupra.com
- 9th Circuit affirms TCPA dismissaljdsupra.com
- RMBS Trustee Wins Partial Dismissal of Investor Claimsjdsupra.com
- Second Circuit Affirms Dismissal of Class Action Alleging That RBS Mislead Investors About RMBS Exposurejdsupra.com
- New York’s Highest Court Affirms Dismissal of RMBS Suit Against DB Structured Products as Time-Barredjdsupra.com
- Second Circuit Affirms Dismissal of New York City's Climate Suitjdsupra.com
- Court Of Appeals Affirms Dismissal Of “Shadow Insurance” Lawsuitsjdsupra.com
- Second Circuit Affirms Dismissal of "Shadow Insurance" Lawsuitsjdsupra.com
- Ninth Circuit Affirms Dismissal of Netflix Antitrust Suitjdsupra.com
- Delaware Supreme Court Affirms Dismissal Of Stockholder Derivative Claims On Issue Preclusion Grounds Based On A Demand-Futility Dismissal Of A Prior Derivative Suit, Holding That The Application Of Issue Preclusion Does Not Violate Federal Due Processjdsupra.com
- 8th Circuit Affirms $5.4M RMBS Indemnification Judgmentjdsupra.com
- 2nd Circuit Affirms RMBS Claims Were Untimelyjdsupra.com
- Fifth Circuit Affirms Dismissal of Product Liability Claims in Truck Rollover Case Applying Texas Statute of Reposejdsupra.com
- Ninth Circuit Affirms Dismissal of Wrongheaded Claim Challenging Discounted Meals for Employeesjdsupra.com
- Ninth Circuit Affirms Dismissal Of Dodd-Frank Whistleblower Case, Using Securities Fraud Standardjdsupra.com
- Ninth Circuit Affirms Dismissal of Breast Implant Cases on Preemption Groundsjdsupra.com
- Ninth Circuit Affirms Dismissal Of Lawsuit Challenging OEM “Destination Charges” As Deceptivejdsupra.com
- Second Circuit Affirms District Court’s Summary Judgment Dismissal Of Securities Fraud Class Action Against Pharmaceutical Companyjdsupra.com
- Ninth Circuit Affirms Dismissal of '40 Act Section 36(b) Excessive Fee Action Against Davisjdsupra.com